Semax

When the Soviet Union invested heavily in neuroscience research during the Cold War, one of the goals was developing compounds that could enhance cognitive performance under stress. Decades later, some of the most interesting peptides to emerge from that research tradition are quietly making their way into the biohacking and nootropic communities of the English-speaking world.

Semax is one of them.

Originally developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, Semax has been in clinical use in Russia and Ukraine for over twenty years, prescribed for stroke rehabilitation, cognitive decline and attention disorders. In the broader research community, it has attracted serious interest as one of the most well-studied peptide nootropics available.

This article breaks down what Semax is, how it works and what the research actually shows.

What Is Semax?

Semax is a synthetic heptapeptide (seven amino acids) derived from a fragment of ACTH (adrenocorticotropic hormone), specifically the 4-7 sequence of ACTH with additional amino acids added to improve stability. The parent compound ACTH is a hormone produced in the pituitary gland with roles in stress response and cortisol regulation, but Semax is structurally modified such that it does not produce the hormonal effects of ACTH. What it retains and amplifies are the neurological and cognitive effects associated with ACTH's interaction with brain receptors.

In Russia, Semax is available as a pharmaceutical nasal spray and has been approved for clinical use since 1996. It is prescribed for ischemic stroke, transient ischaemic attacks (TIAs), optic nerve atrophy and cognitive decline. Outside Russia, it is used primarily in research and biohacking contexts.

How Does Semax Work?

Semax works through several distinct neurological mechanisms, which is one reason its effects span multiple cognitive domains rather than producing a narrow, single-dimension benefit.

BDNF Upregulation
BDNF stands for Brain-Derived Neurotrophic Factor. It is one of the most important proteins in the brain, responsible for the growth, maintenance and survival of neurons, the formation of new synaptic connections and neuroplasticity: the brain's ability to reorganise and form new neural pathways in response to learning and experience.

Semax has been shown in multiple studies to significantly upregulate BDNF expression in the brain, particularly in the hippocampus (the region most associated with memory formation and spatial navigation) and the cortex. This BDNF increase is one of the primary mechanisms through which Semax produces its cognitive effects. Higher BDNF levels are associated with better memory, faster learning, improved mood and greater resilience to neurological stress.

Serotonin and Dopamine Modulation
Semax influences the activity of both serotonin and dopamine systems in the brain. It has been shown to increase the levels of serotonin and dopamine in the striatum and other brain regions, which contributes to its effects on mood, motivation and focus. Unlike pharmaceutical antidepressants or stimulants, this modulation appears to work through indirect mechanisms rather than receptor antagonism or reuptake inhibition.

Enkephalin System Effects
Semax has been shown to influence endogenous opioid signalling through the enkephalin system, which plays a role in pain modulation, mood regulation and stress response. This mechanism may contribute to the anxiolytic (anti-anxiety) effects reported by some users, though Semax is generally considered less specifically anxiolytic than its counterpart Selank.

Neuroprotection
Research has demonstrated Semax's neuroprotective effects in contexts of ischemic injury (reduced blood flow to the brain), oxidative stress and excitotoxicity. These mechanisms are the basis for its clinical use in stroke rehabilitation in Russia, where reducing neuronal death and supporting recovery of function after ischemia is the primary goal.

Improved Cerebral Blood Flow
Some research suggests Semax improves microcirculation in the brain, which contributes to better oxygen and nutrient delivery to neural tissue. This effect may underlie some of the improvements in cognitive performance reported at acute timepoints.

What the Research Shows

The clinical research on Semax is primarily from Russian-language publications, which has limited its exposure to English-language audiences. However, the studies that have been translated and reviewed show consistent findings across several domains.

Cognitive performance: Studies in humans have demonstrated improvements in attention, working memory, processing speed and executive function. These improvements have been documented in healthy subjects as well as in people with cognitive decline, suggesting the effects are not limited to pathological conditions.

Stroke rehabilitation: Clinical trials in Russia have shown improved neurological recovery and functional outcomes in stroke patients treated with Semax compared to controls. The compound is now a standard part of post-stroke protocols in some Russian hospitals.

Attention and focus: Research in individuals with attention difficulties has shown improvements in sustained attention and impulse control, which has driven interest in Semax as an alternative or adjunct to stimulant medications.

Mood and stress resilience: Animal research and clinical reports suggest Semax reduces the neurochemical response to stress and improves emotional stability under cognitive load.

Administration: Why Nasal Spray?

Semax is typically administered as a nasal spray rather than an injection, which makes it one of the more accessible peptides for first-time users. The nasal route allows the peptide to cross the blood-brain barrier directly via the olfactory pathways, which is significantly more efficient for brain delivery than subcutaneous injection.

Doses typically range from 300 to 900mcg per day, administered as drops into the nasal cavity. Timing is often in the morning or early afternoon, as Semax can have activating effects that may interfere with sleep if taken too late in the day.

Semax is also available in a modified form called N-Acetyl Semax, which includes an acetyl group at the N-terminus that increases stability and lipophilicity, potentially improving penetration and duration of effect.

Who Is Semax Most Relevant For?

People exploring Semax typically fall into a few categories:

Cognitive performance: Those looking to improve memory, focus and processing speed in demanding work or study environments.

Neurological recovery: People recovering from brain injury, stroke or other neurological conditions. This is the original clinical indication and the one with the most direct human research support.

Mood and stress resilience: Those experiencing cognitive fog, low motivation or reduced mental clarity related to stress. Semax's BDNF effects and neurotransmitter modulation are relevant here.

Biohackers and longevity-focused individuals: BDNF declines with age, and the cognitive changes this produces, slower memory consolidation, reduced neuroplasticity, are among the most significant aspects of brain aging. Compounds that upregulate BDNF have attracted significant interest in longevity contexts.

Disclaimer: The information in this article is for educational purposes only. STRIATA peptides are research compounds and are not approved medicines. Always consult a qualified healthcare professional before beginning any protocol.